National Survey on Dyslipidemic Patients

Survey on Time to Lipid-lowering Drug Implementation on Dyslipidemic Patients in General Practice.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00701402

Acronym

PRYSME

Enrollment

3655

Registered

2008-06-19

Start date

2008-06-30

Completion date

2009-01-31

Last updated

2009-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Keywords

time to lipid-lowering drug implementation, dyslipidemic patients

Brief summary

The purpose of this observational study is to describe the time to lipid-lowering drug implementation in the management of dyslipidemic patients, according to the cardiovascular risk level.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis of dyslipemia made less than 2 years * Treated by a lipid-lowering drug * Agree to take part in the survey

Exclusion criteria

* Patient included in a clinical trial

Design outcomes

Primary

Measure	Time frame
time to lipid-lowering drug implementation (immediately, treatment within a period 0-3 month and > 3 month, according to the cardiovascular risk level, (0 risk factor, 1 risk factor, 2 risk factors, ≥ 3 risk factors, secondary prevention).	Once

Countries

France

Outcome results